Health

FDA Recalls 12 Million Rohto Eye Drops Over Sterility Concerns

6 min read
Rohto is recalling nearly 12 million eye drop bottles over sterility concerns hero image

FDA Recalls Over 12 Million Rohto Eye Drops Due to Sterility Concerns

The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of more than 12 million bottles of Rohto-brand cooling eye drops. The voluntary recall, initiated on July 14 by manufacturer Rohto-Mentholatum (Vietnam) and distributor The Mentholatum Company (New York), was classified as Class II on July 23, 2026. The reason cited is a 'lack of assurance of sterility,' meaning the manufacturer cannot guarantee the products are free from harmful microorganisms.

Affected products include eight varieties of Rohto Cooling Eye Drops sold both individually and in twin packs, with expiration dates ranging from July 2026 to February 2029. The FDA enforcement report lists 11,960,623 cartons (12,460,649 bottles) impacted. While the recall is voluntary and Class II—indicating temporary or reversible health effects are possible but serious harm is unlikely—consumers are urged to stop using affected lots immediately.

Which Products Are Recalled?

The recall covers the following Rohto Cooling Eye Drops products:

Each product is sold in 0.4 fl oz (13 mL) sterile bottles. The lot numbers and expiration dates for affected units are extensive, spanning multiple production runs from 2025 through 2029. Consumers should carefully check the lot number printed on the carton or bottle label against the recall list provided by the FDA or the manufacturer.

Why Sterility Assurance Matters

Eye drops are sterile solutions by design. The 'lack of assurance of sterility' means the manufacturer cannot confirm that the product is free from bacteria, fungi, or other microbes. This can happen when there are failures in manufacturing, testing, or packaging processes. For ophthalmic products, contamination poses a significant risk because the eyes are highly sensitive and infections can lead to irritation, discharge, or in severe cases, vision impairment.

The FDA has stressed that while the risk of serious harm is low, using non-sterile eye drops could cause mild to moderate reactions such as redness, itching, swelling, or discharge. In rare cases, more serious infections could occur, particularly in individuals with compromised immune systems or pre-existing eye conditions.

Background: A Series of Eye Drop Recalls

This is not the first eye drop recall in recent months. The FDA has been scrutinizing ophthalmic products more closely after several high-profile incidents. In just the past few weeks, the agency also recalled over 2.5 million bottles of prednisoLONE Acetate Ophthalmic Suspension, 1%, a prescription eye drop used to treat inflammation, due to similar sterility concerns. That recall was also labeled Class II.

The increasing frequency of such recalls raises questions about manufacturing oversight in the pharmaceutical industry, particularly for products produced overseas. Rohto-Mentholatum is a Vietnamese manufacturer, and while the FDA does not mandate that all foreign facilities be inspected regularly, enforcement actions can be triggered by adverse event reports or routine audits.

How to Identify Affected Lots

Consumers are advised to check the lot number (a combination of letters and numbers) and the expiration date on their Rohto eye drop bottles. The FDA has published a full list of affected lots. For example, for Rohto Cooling Eye Drops All-in-One, lots include 3H1V (exp. 2026/07), 3J1V (exp. 2026/09), and many others through 6C1V (exp. 2029/02). For Max Strength, lots range from 3H2V (exp. 2026/07) to 4I4V (exp. 2027/08).

If your product matches any of the listed lot numbers and expiration dates, stop using it immediately. You may return it to the place of purchase for a full refund, or dispose of it. The Mentholatum Company has set up a customer service line for queries, and the FDA also provides a number for consumer concerns: 1-888-INFO-FDA (1-888-463-6332).

Consumer Guidance and Next Steps

What to Do If You Have the Recalled Eye Drops

  1. Check the lot number and expiration date on the carton or bottle.
  2. If affected, do not use the product. Even if you have not experienced any symptoms, the lack of sterility means there is a potential risk of infection.
  3. Return the product to the store where purchased, or contact Mentholatum for refund instructions.
  4. Monitor for symptoms such as eye pain, vision changes, persistent redness, or unusual discharge. If any occur, contact your eye care professional immediately.

What the FDA Is Doing

The FDA is working with the manufacturer to ensure a full accounting of distribution and to verify that the recall is effectively communicated to retailers and consumers. The agency has placed this on its enforcement report and encourages healthcare professionals to be alert for patients presenting with eye infections who may have used these drops.

Broader Implications: A Trend in Ophthalmic Safety?

The scale of this recall—over 12 million bottles—underscores the vulnerability of the global supply chain for over-the-counter medications. Rohto is a popular brand among consumers seeking relief from eye dryness, redness, and strain, especially those who spend long hours in front of screens. With summer heat and allergy season, many households likely have these products in their medicine cabinets.

This recall also highlights a growing regulatory focus on sterility assurance. The FDA has issued several warnings and recall notices for various ophthalmic products in the past year, leading to increased scrutiny of manufacturing practices, particularly at facilities in Vietnam and other countries where enforcement oversight may be less frequent.

For consumers, this means it is more important than ever to be vigilant about checking product lots and expiration dates. It also signals that manufacturers must invest in more robust quality control to prevent contamination. The fact that the recall was initiated voluntarily suggests that Rohto-Mentholatum is cooperating with regulators, but it also raises questions about how such a massive quantity of product reached the market without earlier detection.

What Does This Mean for the Future?

Public trust in over-the-counter eye care products is likely to be shaken, at least temporarily. The FDA may increase inspections of foreign manufacturing sites and tighten requirements for sterility testing. Meanwhile, competitors in the eye drop market might use this as an opportunity to emphasize their own quality assurance protocols.

Consumers who rely on artificial tears or decongestant eye drops for everyday comfort should not panic, but they should be proactive. If you have a Rohto product, verify the lot number. For other brands, it's wise to check the FDA's recall list periodically.

As always, if you suspect you have used a recalled product and experience any adverse effects, seeking medical advice is crucial. Eye infections can progress quickly, and early treatment often prevents complications.

In the meantime, the FDA and the manufacturer are working to resolve the issue. Additional information, including the complete list of affected lots, is available on the FDA's website and through the company's customer service. The goal is to remove all potentially non-sterile products from the market and prevent any future lapses in production.

For more health-related recall news, you might also read about the recent UK Cyclospora outbreak and its connection to imported produce, which highlights how quickly contamination can spread through global supply chains.

Stay informed, check your medicine cabinets, and prioritize your health. When it comes to eye infections, the old saying still holds: better safe than sorry.

Comments